Submitted by reuters8361 in business
The U.S. Food and Drug Administration's (FDA) independent experts on Wednesday narrowly voted against recommending the approval of Medtronic's <a href="https://www.reuters.com/markets/companies/MDT.N" target="_blank">(MDT.N)</a> blood pressure treatment devic…